000 01181 a2200337 4500
005 20250515122340.0
264 0 _c20080703
008 200807s 0 0 eng d
022 _a1527-3350
024 7 _a10.1002/hep.22325
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aArroyo, Vicente
245 0 0 _aMolecular adsorbents recirculating system (MARS) and the failing liver: a negative editorial for a positive trial?
_h[electronic resource]
260 _bHepatology (Baltimore, Md.)
_cJun 2008
300 _a2143-4 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aChronic Disease
650 0 4 _aEndpoint Determination
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xtherapy
650 0 4 _aKidneys, Artificial
650 0 4 _aLiver Failure
_xtherapy
650 0 4 _aLiver, Artificial
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aTreatment Outcome
700 1 _aFernandez, Javier
700 1 _aMas, Antoni
700 1 _aEscorsell, Angels
773 0 _tHepatology (Baltimore, Md.)
_gvol. 47
_gno. 6
_gp. 2143-4
856 4 0 _uhttps://doi.org/10.1002/hep.22325
_zAvailable from publisher's website
999 _c18001608
_d18001608